The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ASCO Research Community Forum: Impact on clinical research.
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; AZTherapies; Bristol-Myers Squibb; Celgene; CTI; CTI; Genentech/Roche; Lilly; McGivney Global Advisors
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly
 
Nicholas J. Robert
Employment - McKesson
Leadership - McKesson
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health
Research Funding - Side-Out Foundation (Inst)
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Research Funding - Boehringer Ingelheim; Genentech/Roche; Ignyta; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Merck; Pfizer; Takeda
 
Dax Kurbegov
Employment - HCA Healthcare
Consulting or Advisory Role - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Lilly; Novartis; Seagen; Varian Medical Systems
 
Howard A. Burris III
Employment - HCA Healthcare
Leadership - HCA Healthcare
Stock and Other Ownership Interests - HCA Healthcare
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Eisai (Inst); FORMA Therapeutics (Inst); Incyte (Inst); Janssen (Inst); MedImmune (Inst); Mersana (Inst); Novartis (Inst); Roche/Genentech (Inst); Tolero Pharmaceuticals (Inst)
Research Funding - Agios (Inst); Archer (Inst); Arvinas (Inst); AstraZeneca (Inst); BioAtla (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); CicloMed (Inst); CytomX Therapeutics (Inst); eFFECTOR Therapeutics (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Immunocore (Inst); Incyte (Inst); Janssen (Inst); Jiangsu Hengrui Medicine (Inst); Jounce Therapeutics (Inst); Kyocera (Inst); Lilly (Inst); Loxo (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Revolution Medicines (Inst); Roche/Genentech (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); TG Therapeutics (Inst); Verastem (Inst); Vertex (Inst)
Expert Testimony - Novartis
 
Michael A. Thompson
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Adaptive Biotechnologies; AIM Specialty Health; Celgene; GlaxoSmithKline; Strata Oncology; Syapse; Takeda; VIA Oncology
Research Funding - Abbvie (Inst); ARMO BioSciences (Inst); Bristol-Myers Squibb (Inst); Cancer Research and Biostatistics (Inst); Denovo Biopharma (Inst); Lynx Biosciences (Inst); PrECOG (Inst); Strata Oncology (Inst); Takeda (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Travel, Accommodations, Expenses - GlaxoSmithKline; Syapse; Takeda
Other Relationship - Doximity
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Patricia A. Hurley
No Relationships to Disclose
 
Courtney Davis
No Relationships to Disclose
 
Rogerio Lilenbaum
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genentech
Patents, Royalties, Other Intellectual Property - Section Editor for UpToDate
Travel, Accommodations, Expenses - Roche